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Objectives
To review the current best surgical practice and detail a multi-disciplinary approach that 
could further reduce joint replacement infection.
Methods
Review of relevant literature indexed in PubMed.
Results
Surgical site infection is a major complication following arthroplasty. Despite its rarity in 
contemporary orthopaedic practice, it remains difficult to treat and is costly in terms of both 
patient morbidity and long-term health care resources.
Conclusions
Emphasis on education of patients and all members of the health-care team and raising 
awareness in how to participate in preventative efforts is imperative.
Article focus
 This article reviews the evidence for meth-
ods of reducing surgical site infection in
joint replacement
 We describe a multidisciplinary approach
to prevent surgical site infection 
Key messages 
 Surgical site infection in arthroplasty is
potentially a devastating complication 
 There are many factors that contribute to
cause surgical site infections 
 A multidisciplinary approach can reduce
infection rates
Strengths and limitations
 Strengths: this review of the current liter-
ature provides the reader with a concise
summary of evidence-based advice with
which to make an informed decision on
how to best prevent surgical site infec-
tions in lower limb arthroplasty using a
multidisciplinary approach
 Limitations: there are gaps in knowledge
that require further research
Introduction
Joint replacement is safe and cost effective.1
Prosthetic infection is a major, but infrequent,
complication with a risk of between 0.54%
and 0.63% in England.2 Revision of infected
implants is associated with substantial mor-
bidity and economic cost.3-5 Surgical site infec-
tion (SSI) is multifactorial, involving patient,
surgical and environmental factors. This paper
reviews the current best surgical practice and
describes how a multi-disciplinary approach
can reduce peri-operative joint infection.
Surgical site infection
SSI is present when pathogenic organisms
multiply in a wound causing local signs and
symptoms, and eventually a systemic inflam-
matory response. Figure 1 shows the com-
mon pathogenic organisms responsible for
orthopaedic SSIs.6 Infection rates increase
with a greater number of patient or surgery
specific risk factors7,8 (Table I).
Modifiable patient risk factors
Patient-related factors, such as diabetes mel-
litus (DM) and rheumatoid arthritis (RA), are
Freely available online
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modifiable and certain aspects of management can be
optimised to reduce infection.
Diabetes mellitus. Wound infection has been shown to
be more common in patients with diabetes after arthro-
plasty, and in non-diabetic patients who developed tran-
sient post-operative hyperglycaemia.9 Hyperglycaemia is
associated with increased monocyte susceptibility to
apoptosis10 and impaired neutrophil function (impaired
chemotactic, phagocytic and bactericidal capability).11
Blood glucose levels > 11.1 mmol/l are associated with
SSIs in cardiac surgery,12 and in general surgical patients,
immediate post-operative hyperglycaemia is associated
with SSI.13 The potential to improve in vivo neutrophil
phagocytic function by aggressive glucose control (using
infusion delivery) has also been demonstrated in cardio-
pulmonary bypass patients.14
Rheumatoid arthritis. RA is an independent risk factor
for infection in arthroplasty, but also for revision and sub-
sequent re-infection; pertinent given that these patients
often present earlier for arthroplasty.
Local and systemic corticosteroids have been shown to
delay wound-healing, increase the risk of wound infection
and cause adrenal insufficiency.15 A recent Cochrane review
has questioned the historical practice of providing long-
term users with additional peri-operative steroids (which
may amplify immunosuppression at time of surgery).16
Although disease-modifying anti-rheumatic drugs
(DMARDs) increase the risk of prosthetic joint infection,8
the British Society for Rheumatology (BSR) guidelines
suggest that in most cases these should not be stopped
before joint replacement.17 Methotrexate is a commonly
used first-line drug18 and, despite its inclusion within the
DMARD group, is not considered to increase wound
infection risk, and should not be discontinued before
orthopaedic surgery.19 However, nitrous oxide should be
excluded from the anaesthetic regimen as the interaction
can induce immuno-suppression.20
Tumour necrosis factor (TNF)-α is an inflammatory
cytokine (highly concentrated in the synovial tissue of RA
patients) implicated in joint destruction.21 Any increase in
risk of infection in patients who received anti-TNF therapy
before surgery is debatable.22,23 The BSR state that the
potential benefit of preventing post-operative infections
(by stopping treatment) should be balanced against the
risk of a peri-operative disease flare. If anti-TNF therapy is
to be withheld, it should be discontinued between five
and 20 days before surgery (three to five times the half-life
of the drug), restarting when there is good wound heal-
ing and no evidence of infection.24
Obesity. The effect of obesity on SSI, defined as a body
mass index (BMI) ≥ 30 kg/m2,25 is well documented.26
In a prospective study of over 2800 knee and hip
replacements, Namba et al27 found that the odds ratio
was between 4.2 and 6.7 times the risk for infection in
obese total knee and hip patients, respectively, com-
pared with non-obese patients. Increased length and
complexity of surgery, and poorer vascularisation of
the subcutaneous layer may contribute to this elevated
0
5
10
15
20
25
30
Inpatient n = 384
Readmission n = 404
Pr
op
or
tio
n 
(%
)
Fig. 1
Bar chart showing the distribution of micro-organisms reported as causing
surgical site infections (SSIs) in mandatory orthopaedic categories, Eng-
land, 2011/12 (MSSA, methicillin-sensitive Staphylococcus aureus; MRSA,
methicillin-resistant S. aureus; -ve, negative; ‘Other bacteria’, mostly com-
prising isolates reported as ‘unspecified diphtheroids’, corynebacterium
spp. and ‘other gram-positive organisms’). Adapted with permission from
the Health Protection Agency.6
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risk. Obese patients also require a significantly higher
fraction of inspired oxygen (FIO2) to reach an adequate
arterial oxygen level.28 Referral to a dietician may be
necessary. In extremely obese patients (≥ 50 kg/m2),
bariatric surgery may be indicated. In patients under-
going both bariatric surgery and lower limb arthro-
plasty, the rate of wound infection was 3.5 times lower
in patients who had bariatric surgery first.29 Communi-
cation with the anaesthetist is recommended in order
to evaluate the risk and to discuss increased doses of
peri-operative antibiotics.30
Smoking. Smoking is associated with impaired wound
healing and infection.31 Patients randomised to a
cessation programme six to eight weeks before arthro-
plasty surgery had significantly fewer wound complica-
tions (5% versus 31%), shorter length of stay, fewer re-
operations and non-quantified cardiovascular benefits
compared with those who had continued smoking.32
Screening and decolonisation. The costs associated with
treatment of infections due to methicillin-resistant organ-
isms are 1.5 times higher compared with sensitive
organisms.33 A methicillin-resistant Staphylococcus aureus
Table I. Methods for reducing surgical site infection in joint replacement
Risk factor Summary*
Patient factors
Diabetes mellitus Aggressive glucose control
Rheumatoid arthritis DMARDs and methotrexate should not be stopped
Peri-operative steroids are generally not required
Balance the risks and benefits of stopping anti-TNF – stop at 3 to 5 half-lives pre-operative, restart after wound healing and 
no evidence of infection 
Nitrous oxide should be avoided in patients on methotrexate
Obesity Dietician input to encourage weight loss
Adjust peri-operative antibiotic doses appropriately
In extremely obese consider bariatric surgery before surgery
Smoking Consider a smoking cessation programme
Carrier screening MRSA and MSSA screening based on local guidelines, and decolonise before admission
Pre-operative factors
Patient preparation Shower on day of surgery
If shaving required, use electric clippers on day of surgery
Avoid oil-based skin moisturisers
Antibiotics Prophylactic antibiotics should be given as early as possible in the anaesthetic room, and continued for 24 hours post-oper-
atively (antibiotic type dependent on local guidelines)
Administer antibiotics at least 5 minutes before tourniquet inflation
If cementation is required, antibiotic-impregnated should be used
Peri-operative factors
Theatre Use laminar flow where possible
Keep theatre door opening to a minimum
Personnel Hand wash with antiseptic surgical solution, using a single-use brush or pick for the nails
Before subsequent operations hands should be washed with either an alcoholic hand rub or an antiseptic surgical solution
Double glove and change gloves regularly
Polyprophylene non-woven gowns with adequate mask and hat coverage
Skin preparation Use an alcohol pre-wash followed by a 2% chlorhexadine-alcohol scrub solution
Anaesthetic Maintain normothermia
Maintain normovolaemia
A higher inspired oxygen concentration peri-operatively and for 6 hours post-operative may be of benefit
Drapes Use of iodine-impregnated incise drapes may be of benefit (in patients without allergy)
Blood transfusion Optimise pre-operative haemoglobin 
If possible, transfusion should be avoided intra-operatively and if anticipated should be given more than 48 hours before 
surgery
Antifibrinolytics may indirectly reduce SSI by reducing the need for transfusion
Post-operative factors
Dental procedures Insufficient evidence to recommend the use of prophylactic antibiotics for patients undergoing routine dental procedures 
following joint replacement
* DMARDs, disease-modifying anti-rheumatic drugs; TNF, tumour necrosis factor; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-
sensitive S. aureus; SSI, surgical site infection
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(MRSA) screening programme for all planned NHS sur-
gery was implemented in April 2009,34 with a positive
result prompting decolonisation before admission.
Nasal carriers of methicillin-sensitive S. aureus (MSSA) also
have an increased risk of infection. In a large, randomised
multicentre trial, the risk of developing hospital-associated
S. aureus infection in MSSA-carrier patients who were
decolonised on admission to hospital (mupirocin nasal oint-
ment and chlorhexidine soap) fell by nearly 60% compared
with placebo – a significant reduction from 7.7% to 3.4%.35
Nasal carriage of MSSA is common (approximately 20%35),
and United Kingdom hospitals are beginning to decolonise
patient carriers before joint replacement.
Pre-operative phase surgical risk factors 
Patient preparation before theatre. Patients should shower
with soap on the morning of surgery.36 Washing with an
antiseptic reduces skin bacteria (microflora), but there is
little evidence of a reduction in risk of SSI.37,38 Dry shaving
with a razor may irritate the skin and increase the bacterial
count, so if hair removal is necessary, electric clippers or
depilatory creams on the day of surgery are favoured.36,39
Type of antibiotic prophylaxis. The role of parenteral
prophylactic antibiotics has been studied and accepted
across most surgical specialties,40,41 and may be the sin-
gle most important factor in the prevention of deep
wound infection following lower limb arthroplasty.42
Although many different groups of antibiotics can be
used for prophylaxis, there is insufficient evidence of a
significant difference in the efficacy of cephalosporins,
teicoplanin or penicillin-derivatives, or a benefit of one
generation of cephalosporins over another.43 Cephalo-
sporin use has been associated with Clostridium difficile
colitis, especially in the elderly, but rates are low after
joint replacement (1.7 per 1000 replacements).44
Aminoglycosides, such as gentamicin, can be adminis-
tered locally (in the cement) or parenterally. In a review of
15 000 primary total hip replacements from the Norwe-
gian Arthroplasty Register, the lowest risk of revision was
found in patients who received both systemic and local
(in cement) antibiotics.45
Timing of antibiotic prophylaxis. The United Kingdom
National Institute of Health and Clinical Excellence (NICE)
recommends a single intravenous dose of antibiotic pro-
phylaxis on starting anaesthesia, with a repeat dose if the
operation is longer than the half-life of the antibiotic, or if
blood loss is a significant.46,47 The American Academy of
Orthopaedic Surgeons (AAOS) state that the administra-
tion of antibiotic should precede the skin incision by one
hour, and duration of prophylaxis should not exceed
24 hours.48 Rates of infection have been found to be lowest
for patients who received an antibiotic within two hours of
the incision,40 and there was no difference between one-
and three-day courses of prophylactic antibiotics in terms
of deep-infection rate.49 It would seem prudent to give
antibiotics as early as possible in the anaesthetic room, well
before (at least 5 minutes) tourniquet inflation limits any
further rise in tissue antibiotic concentration.50
Peri-operative phase surgical risk factors
Theatre etiquette. The World Health Organization rec-
ommends that all surgical staff should keep doors to the
operating room closed, except as needed for the passage
of equipment, personnel and the patient.51 Staff should
store essential equipment in the operating room to
decrease theatre traffic.51 Frequency of theatre door-open-
ing is a positive predictor of raised bacterial counts.52
Alcohol rub used in preparation for surgery may be as
effective as hand scrubbing in preventing SSIs.53 There is
no evidence to suggest that any particular alcohol rub is
better than another.54,55
Surgical site preparation in theatre. Skin moisturisers
appear to inhibit the ability of aqueous preparations to
decolonise the skin, and may increase skin bacteria
counts. Avoidance of oil based moisturisers and de-greas-
ing with alcohol pre-wash is recommended.56
A randomised trial of 849 patients undergoing clean-
contaminated surgery in which pre-operative skin prepa-
ration was performed with either 2% chlorhexidine-alco-
hol or aqueous povidone-iodine and paint found that the
rate of SSI was significantly lower in the chlorhexidine-
alcohol group.57
Theatre design. Airborne contaminants are the largest
single contributor to infection.58 One billion skin cells
are shed daily per person,59 with up to 10% carrying
bacteria.60 For orthopaedic surgery, laminar-flow venti-
lation systems have been advocated,61 although they are
not in universal use. These employ high-efficiency par-
ticulate air filters where particles larger than 0.3 μm are
removed (5 μm for conventional theatres). Ultra-clean
air has reduced bacterial and particle concentrations.62
Ultraclean air and prophylactic antibiotics have indepen-
dent and additive effects on reducing infections after
joint arthroplasty.63 There is no dispute that the air
within an effective laminar flow theatre is extremely
clean. However, Brandt et al64 found laminar flow to
have no protective effect against SSI in 99 230 patients.
When 88 311 arthroplasty patients from the New
Zealand joint registry were analysed, revision rates for
deep infection were significantly higher in laminar flow
theatres, despite adjustment for other known vari-
ables.65 As a result of these findings, the authors ques-
tioned the routine use of laminar air flow in arthroplasty,
feeling that the added expense to the health service was
not justified.65 Before abandoning laminar flow, the
interaction with forced air warming should be exam-
ined. A recent study demonstrated that air from outside
the canopy may be drawn into the surgical wound area
when forced air warming (FAW) devices are used, and
deep infection rates were reduced when FAW was aban-
doned in favour of contemporary conductive fabric
warming in joint replacement.66
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Operating personnel clothing. NICE recommends dou-
ble gloving in arthroplasty surgery.46,67 Glove perforation
increases the risk of transmission of blood-borne diseases
and breaks the asepsis barrier, potentially allowing
contamination of the wound and thus increasing the risk of
infection.68,69 Studies have shown that use of a blunt nee-
dle compared with a sharp needle during surgery reduces
glove perforation rates significantly.70,71 Most perforations
are unnoticed (61.5%) and are caused by shearing rather
than penetration by sharps.68 A Cochrane systematic
review supported the use of double gloving, despite no
evidence of a reduction in SSI.72 Glove changing at regular
intervals is an effective way to decrease the length of expo-
sure to bacterial contamination during total hip replace-
ment.69 Latex-free gloves have significantly higher
perforation rates when compared with latex gloves.73
 Hooper et al,65 in their ten-year New Zealand joint reg-
istry study, found that the rate of revision
for early deep infection had not been reduced by space
suits compared with a normal theatre gown and mask,
when analysed independently of laminar flow.
Surgical drapes. NICE recommend an incise drape
impregnated with iodophore should be used unless the
patient has an iodine allergy.46 Although a Cochrane
review concluded that these drapes did not make any
difference to infection rates,74 only one trial involved
orthopaedic surgery, which showed no difference in
post-operative wound infection rates following hip frac-
ture surgery with or without non-impregnated Opsite
(Smith & Nephew Wound Management, Hull, United
Kingdom).75
Body core temperature. Peri-operative hypothermia is
common during major surgery and causes vasoconstric-
tion, resulting in a reduction in subcutaneous tissue perfu-
sion and an increased risk of infection.76 Peri-operative
hypothermia is associated with increased blood loss, cardiac
events, increased transfusion requirements and longer peri-
operative hospital stay.77 Heat loss in theatre is largely con-
ductive and convective, with a small amount of radiated
heat. Laminar flow significantly increases convective heat
loss in exposed patients, mitigated by active warming.
Warming patients undergoing clean general surgery
significantly reduces wound infection.78 A similar report
of cholecystectomy patients found nearly a six-fold differ-
ence in the incidence of wound infection between nor-
mothermic and hypothermic patients.79 The importance
of maintaining peri-operative normothermia has been
recognised in the recent NICE guidelines.80 However, it is
notable that warming has never been proven to reduce
SSIs in orthopaedic implant surgery, and their effect on
laminar flow and clean air needs further study.
Oxygen delivery and fluid management. Increasing tis-
sue oxygen concentrations has been hypothesised to
increase the killing potential of phagocytes and thus
decrease infective complications in the peri-operative
period.81 Enhancement of tissue oxygen delivery can be
achieved via improvement of cardiac output and/or
oxygen content of the blood. Increased subcutaneous
oxygen concentrations can be achieved by increasing the
inspired oxygen concentration intra-operatively (from
30% to 80%), and by providing supplemental oxygen
post-operatively. There are studies supporting the use of
supplemental oxygen to reduce wound infections in gen-
eral surgery, but these have never been extrapolated to
arthroplasty surgery.82-84
Both hypovolaemia and hypervolaemia (oedema) can
be detrimental to tissue oxygenation. Current guidance
would support optimal tissue oxygenation by mainte-
nance of a normovolaemic state throughout the peri- and
early post-operative period by judicious use of intrave-
nous fluids.85,86
Anaesthetic technique. The question of whether
regional anaesthesia is superior to general anaesthesia
has yet to be adequately assessed, although a recent ret-
rospective population based study found a significantly
lower 30-day rate of SSI in patients undergoing lower
limb arthroplasty under a spinal anaesthetic compared
with patients undergoing similar procedures under gen-
eral anaesthetic.87 An RCT examining the potentially ben-
eficial effect of nitrous oxide avoidance failed to show a
reduction in SSI. Co-administered anaesthetic and seda-
tive agents may impair immune responses directly,
thereby increasing infection,88 and regional anaesthesia
may offer particular benefits such as improved tissue oxy-
gen delivery (through vasodilation). Randomised con-
trolled trials are required to address whether choice of
agent (such as use of an alpha-2 adrenergic versus GAB-
Aergic sedative) affects outcome.88,89
Anaemia. In a prospective cohort study pre-operative
anaemia was associated with increased post-operative
infections in patients undergoing hip arthroplasty.90 This
effect was associated with an increase in post-operative
blood transfusion.
Blood transfusion. There are no specific recommenda-
tions from NICE regarding transfusions. Though it is
clear that blood loss is primarily a surgical responsibility,
regional anaesthetic techniques and attention to peri-
operative normothermia are associated with reduced
blood loss. Transfusion related immunomodulation is
recognised in trauma patients91 with a 5% increase risk
of infection for every unit of red cells given.92 A signifi-
cant increase in infection rates following hip replace-
ment are seen in patients receiving allogeneic red blood
cells, with higher risk with more units transfused.93
There is clearly a risk-benefit balance between immuno-
suppression and enhancing oxygen supply to hypo-
perfused tissue. If possible, blood transfusion should be
avoided intra-operatively94 and, if anticipated, should be
administered at least 48 hours before surgery to maxi-
mise oxygen transportation of transfused blood.
Addressing pre-operative anaemia reduces post-
operative transfusion requirements.
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The use of antifibrinolytics, such as tranexamic acid,
prevent blood loss following major arthroplasty.95
Although there is insufficient data to comment on their
ability to prevent post-operative infection, they may indi-
rectly reduce the risk by reducing transfusion require-
ment and improving the wound environment. 
Post-operative period
Thromboembolic prophylaxis. NICE guidelines state that
patients undergoing lower limb joint replacements should
have either prophylactic low-molecular-weight heparin
(LMWH) or an orally active direct factor Xa inhibitor for
28 (or 35) days following hip replacement and 14 days fol-
lowing a knee replacement.96 No increased risk of infection
was found with LMWH97 but prolonged ooze is a recog-
nised risk,98 and each day of prolonged wound drainage
increases risk of wound infection by between 29% and
42% following arthroplasty.98 Wound related complica-
tions following arthroplasty may increase in patients who
receive a factor Xa inhibitor for thromboprophylaxis.99
Dental care and other procedures. It has been sug-
gested that patients requiring dental care post-arthro-
plasty should receive prophylactic antibiotics.100 Other
authors argue that there is little evidence to suggest that
bacteraemia associated with dental procedures causes
prosthetic joint infection101; simple tasks, such as brush-
ing teeth and chewing, can produce a greater bacterae-
mia than one dental procedure and it would be better
practice for the surgeon to ensure dentition and oral
health are up to standard before elective orthopaedic sur-
gery. Currently in the United Kingdom, the British Dental
Association does not recommend antibiotics in patients
undergoing dental procedures and who are at risk of
infective endocarditis.102
Conclusions
SSI following routine surgery can have disastrous conse-
quences for the patients and causes a significant drain on
the resources of healthcare providers. A multidisciplinary
approach is essential in order to reduce infection rates.
Every possible step must be exercised to reduce contam-
ination of the surgical wound and to optimise the
patient’s capacity to eradicate any colony forming units
entering the wound. Common sense approaches are
required to minimise or correct physiological distur-
bances and attention should be given to theatre design
and etiquette, identification and control of MSSA carriers
and the appropriate and timely use of prophylactic anti-
biotics. It is important to emphasise the need to educate
the patient and all members of the health-care team, and
to increase awareness of the importance of their partici-
pation in preventive efforts.
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